Results for tag: "Plerixafor"

Plerixafor is a drug used in oncology to treat certain types of cancer. It is a chemotherapeutic agent that works by blocking the action of a protein called CXCR4, which is involved in the growth and spread of cancer cells. Plerixafor is used in combination with other drugs to treat multiple myeloma, non-Hodgkin's lymphoma, and certain types of leukemia. It is also used to mobilize stem cells from the bone marrow for collection and transplantation. Plerixafor is marketed by Sanofi, a French pharmaceutical company, and is available in the United States, Europe, and other countries. Other companies involved in the market include Novartis, Pfizer, and Merck. Show Less Read more